Literature DB >> 25917782

A stable chemical SUMO1-Ubc9 conjugate specifically binds as a thioester mimic to the RanBP2-E3 ligase complex.

Stefanie Sommer1, Tobias Ritterhoff2, Frauke Melchior3, Henning D Mootz4.   

Abstract

Ubiquitin and ubiquitin-like (Ubl) modifiers such as SUMO are conjugated to substrate proteins by E1, E2, and E3 enzymes. In the presence of an E3 ligase, the E2∼Ubl thioester intermediate becomes highly activated and is prone to chemical decomposition, thus making biochemical and structural studies difficult. Here we explored a stable chemical conjugate of the E2 enzyme from the SUMO pathway, Ubc9, with its modifier SUMO1 as a structural analogue of the Ubc9SUMO1 thioester intermediate, by introducing a triazole linkage by biorthogonal click chemistry. The chemical conjugate proved stable against proteolytic cleavage, in contrast to a Ubc9-SUMO1 isopeptide analogue obtained by auto-SUMOylation. Triazole-linked Ubc9-SUMO1 bound specifically to the preassembled E3 ligase complex RanBP2/RanGAP1*SUMO1/Ubc9, thus suggesting that it is a suitable thioester mimic. We anticipate interesting prospects for its use as a research tool to study protein complexes involving E2 and E3 enzymes.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  SUMO; biological activity; click chemistry; enzyme catalysis; post-translational modifications; ubiquitin

Mesh:

Substances:

Year:  2015        PMID: 25917782     DOI: 10.1002/cbic.201500011

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  1 in total

1.  A cascading activity-based probe sequentially targets E1-E2-E3 ubiquitin enzymes.

Authors:  Monique P C Mulder; Katharina Witting; Ilana Berlin; Jonathan N Pruneda; Kuen-Phon Wu; Jer-Gung Chang; Remco Merkx; Johanna Bialas; Marcus Groettrup; Alfred C O Vertegaal; Brenda A Schulman; David Komander; Jacques Neefjes; Farid El Oualid; Huib Ovaa
Journal:  Nat Chem Biol       Date:  2016-05-16       Impact factor: 15.040

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.